enGene Therapeutics Inc. (ENGN) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $53.76M | +39.4% |
| 2024 | $38.56M | +166.4% |
| 2023 | $14.47M | -69.5% |
| 2022 | $47.41M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $53.76M | +39.4% |
| 2024 | $38.56M | +166.4% |
| 2023 | $14.47M | -69.5% |
| 2022 | $47.41M | — |